Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a keyhole mesh fix ventral hernias safely?

NCT ID NCT07792135

Disease control Sponsor: Sohag University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 28, 2026 · Last updated Aug 28, 2026

Summary

This trial evaluates the safety and effectiveness of laparoscopic IPOM repair, a keyhole surgery that places a mesh inside the abdomen to fix ventral hernias. Researchers at Sohag University will track complications, recovery, and short-term outcomes in 30 adults with primary ventral hernias. The goal is to see if this technique works well in a regional hospital setting.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
laparoscopic intraperitoneal onlay mesh (IPOM) repair
What this could lead to
If successful, this could support IPOM as a safe, effective option for ventral hernia repair, potentially improving recovery and reducing complications in regional hospitals.
What could go wrong
This is a small, single-center study with only 30 patients, so results may not apply broadly. Risks include mesh-related complications, infection, or hernia recurrence, and the short follow-up may miss long-term issues.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study will include adult patients with primary ventral hernias who are eligible for elective laparoscopic ventral hernia repair using the IPOM technique Adult patients aged 18 years or older. Patients diagnosed clinically and/or radiologically with primary ventral hernia. Patients planned for elective laparoscopic ventral hernia repair using the IPOM technique.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria 1. Adult patients aged 18 years or older. 2. Patients diagnosed clinically and/or radiologically with primary ventral hernia. 3. Patients planned for elective laparoscopic ventral hernia repair using the IPOM technique. Exclusion Criteria 1. Patients unfit for general anesthesia or laparoscopic surgery. 2. Complicated hernias requiring emergency open surgery, such as strangulated hernia, bowel ischemia, perforation, or generalized peritonitis. 3. Incisional ventral hernias 4. Recurrent hernias 5. Active abdominal wall infection, skin ulceration over the hernia, or contaminated operative field. 6. Pregnancy. 7. Refusal to provide informed consent or inability to complete postoperative follow-up.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hernia abdominal wall are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hernia, Abdominal

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hernia abdominal wall Laparoscopic

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.